Income Statement of the Merck Group

Sales

2,434.3

2,347.0

7,381.4

6,472.6

Royalty, license and commission income

97.3

90.8

269.3

272.1

Total revenues

2,531.6

2,437.8

7,650.7

6,744.7

Cost of sales

–679.8

–619.7

–2,079.8

–1,623.5

Gross margin

1,851.8

1,818.2

5,570.9

5,121.2

Marketing and selling expenses

–586.3

–573.3

–1,782.9

–1,581.7

Royalty, license and commission expenses

–133.9

–115.8

–363.7

–355.3

Administration expenses

–124.5

–128.0

–375.7

–347.5

Other operating expenses and income

–89.8

–91.0

–457.3

–335.4

Research and development

–371.0

–348.6

–1,119.6

–1,034.6

Amortization of intangible assets

–212.9

–198.2

–780.1

–484.7

Investment result

–0.1

0.3

1.9

2.5

Operating result

333.3

363.5

693.4

984.4

Exceptional items

–0.3

–

146.6

–1.2

Earnings before interest and tax (EBIT)

333.0

363.5

840.0

983.2

Financial result

–70.5

–74.2

–213.3

–191.1

Profit before tax

262.5

289.3

626.7

792.2

Income tax

–32.6

–74.8

–136.7

–196.2

Profit after tax

229.9

214.5

490.0

596.0

Non-controlling interest

–3.3

–3.7

–8.2

–10.4

Net profit after non-controlling interest

226.6

210.8

481.8

585.6

Earnings per share (in €)

basic

1.04

0.97

2.22

2.69

diluted

1.04

0.97

2.22

2.69